168 related articles for article (PubMed ID: 15972691)
21. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
[TBL] [Abstract][Full Text] [Related]
22. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
23. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
24. The roles of Smad2 and Smad3 in the development of chemically induced skin tumors in mice.
Tannehill-Gregg SH; Kusewitt DF; Rosol TJ; Weinstein M
Vet Pathol; 2004 May; 41(3):278-82. PubMed ID: 15133179
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
[TBL] [Abstract][Full Text] [Related]
27. SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.
Schiemann BJ; Neil JR; Schiemann WP
Mol Biol Cell; 2003 Oct; 14(10):3977-88. PubMed ID: 14517312
[TBL] [Abstract][Full Text] [Related]
28. Receptor-regulated and inhibitory Smads are critical in regulating transforming growth factor beta-mediated Meckel's cartilage development.
Ito Y; Bringas P; Mogharei A; Zhao J; Deng C; Chai Y
Dev Dyn; 2002 May; 224(1):69-78. PubMed ID: 11984875
[TBL] [Abstract][Full Text] [Related]
29. Involvement of p300 in TGF-beta/Smad-pathway-mediated alpha2(I) collagen expression in mouse mesangial cells.
Kanamaru Y; Nakao A; Tanaka Y; Inagaki Y; Ushio H; Shirato I; Horikoshi S; Okumura K; Ogawa H; Tomino Y
Nephron Exp Nephrol; 2003; 95(1):e36-42. PubMed ID: 14520013
[TBL] [Abstract][Full Text] [Related]
30. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
[TBL] [Abstract][Full Text] [Related]
31. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis.
Kim JH; Kim BK; Moon KC; Hong HK; Lee HS
Kidney Int; 2003 Nov; 64(5):1715-21. PubMed ID: 14531804
[TBL] [Abstract][Full Text] [Related]
32. TGF-beta1 induction of the adenine nucleotide translocator 1 in astrocytes occurs through Smads and Sp1 transcription factors.
Law AK; Gupta D; Levy S; Wallace DC; McKeon RJ; Buck CR
BMC Neurosci; 2004 Jan; 5():1. PubMed ID: 14720305
[TBL] [Abstract][Full Text] [Related]
33. TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation.
Fiocchi C
J Clin Invest; 2001 Aug; 108(4):523-6. PubMed ID: 11518725
[No Abstract] [Full Text] [Related]
34. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
35. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation.
Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H
Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-beta signaling is differentially inhibited by Smad2D450E and Smad3D407E.
Kondo M; Suzuki H; Takehara K; Miyazono K; Kato M
Cancer Sci; 2004 Jan; 95(1):12-7. PubMed ID: 14720321
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the transforming growth factor-beta/Smad signaling pathway in the epithelium of oral lichen.
Karatsaidis A; Schreurs O; Axéll T; Helgeland K; Schenck K
J Invest Dermatol; 2003 Dec; 121(6):1283-90. PubMed ID: 14675171
[TBL] [Abstract][Full Text] [Related]
38. The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation.
Seo SR; Lallemand F; Ferrand N; Pessah M; L'Hoste S; Camonis J; Atfi A
EMBO J; 2004 Oct; 23(19):3780-92. PubMed ID: 15359284
[TBL] [Abstract][Full Text] [Related]
39. Loss of Smad3 modulates wound healing.
Ashcroft GS; Roberts AB
Cytokine Growth Factor Rev; 2000; 11(1-2):125-31. PubMed ID: 10708960
[TBL] [Abstract][Full Text] [Related]
40. Smad3-deficient chondrocytes have enhanced BMP signaling and accelerated differentiation.
Li TF; Darowish M; Zuscik MJ; Chen D; Schwarz EM; Rosier RN; Drissi H; O'Keefe RJ
J Bone Miner Res; 2006 Jan; 21(1):4-16. PubMed ID: 16355269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
